{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:33:59Z","timestamp":1740141239813,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"WHO funds for surveillance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12985-018-0990-y","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T22:36:17Z","timestamp":1524782177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4960-4222","authenticated-orcid":false,"given":"Mary Bridget","family":"Nanteza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnabas","family":"Bakamutumaho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Kisakye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prossy","family":"Namuwulya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Bukenya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson","family":"Katushabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Bwogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Rutebarika","family":"Byabamazima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicksy","family":"Gumede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"990_CR1","unstructured":"EA C. Spread of vaccine-derived poliovirus from a paralytic case in an Immunodeficient child: an insight into the natural evolution of oral polio vaccine. Virology. 2005;"},{"issue":"Suppl 1","key":"990_CR2","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","volume":"210","author":"CC Burns","year":"2014","unstructured":"Burns CC, et al. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283\u201393.","journal-title":"J Infect Dis"},{"issue":"7","key":"990_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jiq140","volume":"203","author":"S Wassilak","year":"2011","unstructured":"Wassilak S, et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis. 2011;203(7):898\u2013909.","journal-title":"J Infect Dis"},{"key":"990_CR4","unstructured":"World Health Organization. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2003-June 2004. Wkly Epidemiol Rec. 2004;79:393\u2013399."},{"issue":"2","key":"990_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088442","volume":"9","author":"S Sharif","year":"2014","unstructured":"Sharif S, et al. Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of southern Afghanistan during June 2009-February 2011. PLoS One. 2014;9(2):e88442.","journal-title":"PLoS One"},{"key":"990_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-3292-4_11","volume":"1387","author":"J Jorba","year":"2016","unstructured":"Jorba J. Phylogenetic analysis of poliovirus sequences. Methods Mol Biol. 2016;1387:227\u201337.","journal-title":"Methods Mol Biol"},{"key":"990_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew OM, et al. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587\u2013635.","journal-title":"Annu Rev Microbiol"},{"issue":"Suppl 1","key":"990_CR8","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1093\/infdis\/175.Supplement_1.S176","volume":"175","author":"JP Alexander Jr","year":"1997","unstructured":"Alexander JP Jr, Gary HE Jr, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis. 1997;175(Suppl 1):S176\u201382.","journal-title":"J Infect Dis"},{"key":"990_CR9","unstructured":"Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases: Elsevier Health Sciences, 8th Edition; 2014."},{"key":"990_CR10","volume-title":"WHO\/HQ","author":"Organization, W.H","year":"2010","unstructured":"Organization, W.H. Summary of discussions and recommendations, 16th informal consultation of the global polio laboratory network, 22\u201323 September 2010. In: WHO\/HQ. Geneva: World Health Organization; 2010."},{"key":"990_CR11","unstructured":"Centers for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011. MMWR Morb Mortal Wkly Rep. 2011;60(25):846\u201350."},{"key":"990_CR12","unstructured":"Center for disease control and prevention (CDC). Update on Vaccine-Derived Polioviruses --- Worldwide, January 2008--June 2009 September 18. 2009;58(36):1002\u20131006."},{"key":"990_CR13","volume-title":"Global Polio Eradication Initiative: Polio Eradication and Endgame Strategic Plan (2013\u20132018)","author":"Organization, W.H","year":"2013","unstructured":"Organization, W.H. Global Polio Eradication Initiative: Polio Eradication and Endgame Strategic Plan (2013\u20132018). Geneva: Report No, WHO\/POLIO\/13.02; 2013."},{"issue":"6","key":"990_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3201\/eid1806.120037","volume":"18","author":"N Gumede","year":"2012","unstructured":"Gumede N, Muthambi V, Schoub BD. Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011. Emerg Infect Dis. 2012;18(6):992\u20134.","journal-title":"Emerg Infect Dis"},{"key":"990_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jtbi.2014.09.026","volume":"364","author":"JH Kim","year":"2015","unstructured":"Kim JH, Rho SH. Transmission dynamics of oral polio vaccine viruses and vaccine-derived polioviruses on networks. J Theor Biol. 2015;364:266\u201374.","journal-title":"J Theor Biol"},{"issue":"10","key":"990_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3201\/eid1910.130028","volume":"19","author":"N Gumede","year":"2013","unstructured":"Gumede N, et al. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. Emerg Infect Dis. 2013;19(10):1583\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"990_CR17","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/infdis\/jit831","volume":"209","author":"SB Troy","year":"2014","unstructured":"Troy SB, et al. Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks. J Infect Dis. 2014;209(11):1693\u20139.","journal-title":"J Infect Dis"},{"issue":"4","key":"990_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.idc.2015.07.003","volume":"29","author":"JR Garon","year":"2015","unstructured":"Garon JR, Cochi SL, Orenstein WA. The challenge of global poliomyelitis eradication. Infect Dis Clin N Am. 2015;29(4):651\u201365.","journal-title":"Infect Dis Clin N Am"},{"key":"990_CR19","unstructured":"Center for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007. MMWR. 2007;56(38):996\u20131001."},{"key":"990_CR20","unstructured":"Center for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep. 2012;61:741."},{"issue":"23","key":"990_CR21","first-page":"640","volume":"64","author":"OM Diop","year":"2015","unstructured":"Diop OM, et al. Update on vaccine-derived polioviruses-worldwide, January 2014-march 2015. MMWR Morb Mortal Wkly Rep. 2015;64(23):640\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Pt 5","key":"990_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1099\/vir.0.18974-0","volume":"84","author":"G Buttinelli","year":"2003","unstructured":"Buttinelli G, et al. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol. 2003;84(Pt 5):1215\u201321.","journal-title":"J Gen Virol"},{"key":"990_CR23","unstructured":"World Health Organisation, Polio Laboratory Manual, 4th Edition; 2004."},{"key":"990_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jviromet.2013.11.017","volume":"197","author":"DR Kilpatrick","year":"2014","unstructured":"Kilpatrick DR, et al. Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR. J Virol Methods. 2014;197:25\u20138.","journal-title":"J Virol Methods"},{"issue":"6","key":"990_CR25","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1128\/JCM.00702-09","volume":"47","author":"DR Kilpatrick","year":"2009","unstructured":"Kilpatrick DR, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol. 2009;47(6):1939\u201341.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"990_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1128\/JCM.02406-14","volume":"53","author":"M Taniuchi","year":"2015","unstructured":"Taniuchi M, et al. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture. J Clin Microbiol. 2015;53(1):206\u201311.","journal-title":"J Clin Microbiol"},{"key":"990_CR27","unstructured":"Qiagen, QIAamp Viral RNA Mini Kit. \n                    https:\/\/www.qiagen.com\/us\/shop\/sample-technologies\/rna\/viral-rna\/qiaamp-viral-rna-mini-kit\/#orderinginformation\n                    \n                  ."},{"issue":"1\u20132","key":"990_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jviromet.2011.03.020","volume":"174","author":"DR Kilpatrick","year":"2011","unstructured":"Kilpatrick DR, et al. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods. 2011;174(1\u20132):128\u201330.","journal-title":"J Virol Methods"},{"key":"990_CR29","unstructured":"Qiagen, QIAquick PCR Purification Kit. \n                    https:\/\/www.qiagen.com\/us\/shop\/sample-technologies\/dna\/dna-clean-up\/qiaquick-pcr-purification-kit\/#orderinginformation\n                    \n                  ."},{"key":"990_CR30","unstructured":"Scientific, T.F., NanoDrop\u2122 2000\/2000c Spectrophotometers. \n                    https:\/\/www.thermofisher.com\/order\/catalog\/product\/ND-2000\n                    \n                  ."},{"issue":"7","key":"990_CR31","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","volume":"33","author":"S Kumar","year":"2016","unstructured":"Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870\u20134.","journal-title":"Mol Biol Evol"},{"key":"990_CR32","unstructured":"Sunrise, Mass Polio immunisation campaign on in 57 districts; 2016. \n                    http:\/\/www.sunrise.ug\/category\/opinions\/editorial\n                    \n                  ."},{"issue":"11","key":"990_CR33","first-page":"242","volume":"63","author":"OM Diop","year":"2014","unstructured":"Diop OM, et al. Update on vaccine-derived polioviruses-worldwide, July 2012-December 2013. MMWR Morb Mortal Wkly Rep. 2014;63(11):242\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"990_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","volume":"13","author":"PA Patriarca","year":"1991","unstructured":"Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries. Rev Infect Dis. 1991;13(5):926\u201339.","journal-title":"Rev Infect Dis"},{"issue":"25","key":"990_CR35","first-page":"699","volume":"64","author":"LM Hampton","year":"2015","unstructured":"Hampton LM. Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine-worldwide, 2013-2016. MMWR-Morbidity mortality weekly report. 2015;64(25):699\u2013702.","journal-title":"MMWR-Morbidity mortality weekly report"},{"issue":"6","key":"990_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","volume":"15","author":"J Garon","year":"2016","unstructured":"Garon J, et al. Polio endgame: the global switch from tOPV to bOPV. Expert Rev Vaccines. 2016;15(6):693\u2013708.","journal-title":"Expert Rev Vaccines"},{"issue":"23","key":"990_CR37","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1128\/JVI.01174-13","volume":"87","author":"H Al-Hello","year":"2013","unstructured":"Al-Hello H, et al. Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia. J Virol. 2013;87(23):13076\u201380.","journal-title":"J Virol"},{"issue":"1","key":"990_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.virusres.2008.07.006","volume":"137","author":"S Shahmahmoodi","year":"2008","unstructured":"Shahmahmoodi S, et al. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008;137(1):168\u201372.","journal-title":"Virus Res"},{"issue":"1","key":"990_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/JVI.01532-15","volume":"90","author":"M Famulare","year":"2016","unstructured":"Famulare M, et al. Sabin vaccine reversion in the field: a comprehensive analysis of Sabin-like poliovirus isolates in Nigeria. J Virol. 2016;90(1):317\u201331.","journal-title":"J Virol"},{"issue":"suppl_1","key":"990_CR40","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1093\/infdis\/jiu060","volume":"210","author":"G Wahjuhono","year":"2014","unstructured":"Wahjuhono G, et al. Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance. J Infect Dis. 2014;210(suppl_1):S347\u201352.","journal-title":"J Infect Dis"},{"issue":"12","key":"990_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083975","volume":"8","author":"Z Tao","year":"2013","unstructured":"Tao Z, et al. Isolation and characterization of a type 2 vaccine-derived poliovirus from environmental surveillance in China, 2012. PLoS One. 2013;8(12):e83975.","journal-title":"PLoS One"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0990-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-0990-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0990-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:04:03Z","timestamp":1556305443000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-0990-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-0990-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Additional file .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"77"}}